Literature DB >> 31933782

Function and mechanism of combined PARP-1 and BRCA genes in regulating the radiosensitivity of breast cancer cells.

Wei Zhao1,2, Hongbo Hu1,3, Qiyan Mo1, Ying Guan1, Ye Li1, Youqing Du1, Ling Li1.   

Abstract

OBJECTIVE: To study the function and mechanism of combined PARP-1 and BRCA genes in regulating the radiosensitivity of breast cancer cells by poly ADP-ribose polymerase-1 (PARP-1) inhibitor 3-amion benzamide (3-AB) onBRCA mutant and non-mutant breast cancer cells.
METHODS: Four groups of BRCA mutant cells MDA-MB-436 and BRCA non-mutant cells MDA-MB-231 were divided respectively into control (CTRL), ionizing radiation alone (IR), 3-AB alone (3-AB), and ionizing radiation combined with 3-AB (IR+3-AB) groups. The γ-H2AX foci were detected by immunofluorescence assay to show the DNA double-strand damage. The clonogenic cell survival assay was applied to evaluate the radiosensitivity of breast cancer cells, and flow cytometry was used to assess the percentage of apoptosis cells.
RESULTS: The apoptosis rate of MDA-MB-436 cells was significantly increased compared with MDA-MB-231 cells treated with irradiation, and 3-AB could further enhance the effect. Similarly, the result of γ-H2AX foci detection showed that DNA double-stranded damage of the MDA-MB-436 cells was significantly greater than that of MDA-MB-231 cells (t = 4.57, P < 0.05), and the DNA damage of MDA-MB-436 cells in IR+3-AB group was the most remarkable. The difference was significant (t = 3.26, P < 0.05). In the same group, compared with MDA-MB-231 cells, MDA-MB-436 cells had the significantly greater apoptosis rate (t = 2.96, P < 0.05). The apoptosis rate of MDA-MB-436 cells in the IR+3-AB group showed by flow cytometry was highest (t = 3.81, P < 0.05).
CONCLUSIONS: Compared with non-BRCA mutant MDA-MB-231 cells, the BRCA mutant breast cancer MDA-MB-436 cells could incur significantly greater DNA damage, and therefore the radiosensetivity of MDA-MB-436 cells is higher than that of MDA-MB-231 cells. The inhibitor of PARP-1, which can block the repair of single-strand damage caused by radiation, can further enhance the level of apoptosis and radiosensitivity of BRCA-mutant cells. IJCEP
Copyright © 2019.

Entities:  

Keywords:  BRCA gene; PARP-1 inhibitor; breast cancer; radiosensitivity

Year:  2019        PMID: 31933782

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  5 in total

Review 1.  PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?

Authors:  Anthony Gonçalves; Alexandre Bertucci; François Bertucci
Journal:  Cancers (Basel)       Date:  2020-05-27       Impact factor: 6.639

Review 2.  Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy.

Authors:  May Elbanna; Nayela N Chowdhury; Ryan Rhome; Melissa L Fishel
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

3.  Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?

Authors:  Alessandro Lavoro; Aurora Scalisi; Saverio Candido; Guido Nicola Zanghì; Roberta Rizzo; Giuseppe Gattuso; Giuseppe Caruso; Massimo Libra; Luca Falzone
Journal:  Int J Oncol       Date:  2022-04-06       Impact factor: 5.650

4.  Combining Carbon-Ion Irradiation and PARP Inhibitor, Olaparib Efficiently Kills BRCA1-Mutated Triple-Negative Breast Cancer Cells.

Authors:  Miki Kawanishi; Mayumi Fujita; Kumiko Karasawa
Journal:  Breast Cancer (Auckl)       Date:  2022-03-23

Review 5.  Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy.

Authors:  Stephen A Jannetti; Brian M Zeglis; Michael R Zalutsky; Thomas Reiner
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.